【M&A Restructuring】 - Borui Communications: Plans to acquire 51% stake in Meijing Technology for CNY 66.49 million. - Xiamen Airport: Plans to acquire 100% stake in Zhaoxiang Technology, a subsidiary of its controlling shareholder. - Tianyouwei: Plans to purchase 100% stake in Kramer Automotive Systems Ltd. for EUR 1 million.
【Hotspots】 - Longzhou Co., Ltd. (5 consecutive limit-ups): Clarifies no involvement in commercial aerospace business. - Shengxing Co., Ltd. (3 consecutive limit-ups): Currently planning private share issuance. - Bona Film Group (2 consecutive limit-ups): Low investment return ratio for "Avatar 3" with no significant short-term impact. - Daye Co., Ltd.: Invested Jiangbei Co. focuses on aerospace R&D; current net profit remains modest. - Yifang Biotech: Plans H-share issuance and listing on HKEX. - LONGi Green Energy: Terminates overseas GDR issuance.
【Equity Changes】 - Zaisheng Technology: Controlling shareholder Guo Mao plans to transfer 6.04% stake via agreement. - Jiuzhitang: China National Pharmaceutical Investment to acquire 5% stake. - Jiamei Packaging: Controlling shareholder plans change of control; trading halted. - Guao Technology (Rights Protection): Actual controller plans change of control; trading remains suspended. - Haimo Technology: Plans to sell entire stake in subsidiary Sitan Instruments. - Layn Natural Ingredients: Plans control change and asset acquisition; trading halted from Dec 10. - Fulede: Plans to transfer 4.1 million shares in Haigude, expecting CNY 180 million investment gain.
【Shareholding Changes & Buybacks】 - HuiTai Medical: Plans CNY 200–250 million share buyback. - Songcheng Performance: Plans CNY 100–200 million share buyback. - Impulse Fitness: Controlling shareholder plans CNY 60–120 million share purchase. - Jingu Holdings: Plans CNY 30–60 million share buyback. - Financial Street: Hexie Health recently acquired 7.04 million shares. - Aokang International (Rights Protection): Shareholder plans ≤3% stake reduction. - Digital China: Controlling shareholder plans ≤3% stake reduction. - Kutesmart: Controlling shareholder’s concerted parties plan ≤2% stake reduction. - Donghua Testing: Controlling shareholder and concerted parties plan ≤1.99% stake reduction. - Lixin New Energy: Shareholder Shandong Electric Power plans ≤1% stake reduction.
【Operating Data】 - China Life Insurance: Total premiums exceed CNY 700 billion as of Nov 30, 2025. - China Merchants Shekou: November contracted sales reach CNY 14.09 billion. - Shouqi Co., Ltd. (Rights Protection): Jan–Nov contracted sales total CNY 15.99 billion. - New Wufeng: November hog sales hit 575,500 heads, up 80.97% YoY. - Zhengbang Technology: November hog sales revenue rises 8.55% MoM to CNY 741 million. - Luoniushan: November hog sales revenue up 13.57% YoY to CNY 111 million. - Tiankang Biology: November hog sales revenue grows 1.2% MoM to CNY 420 million. - Tangrenshen: November hog sales revenue drops 24.05% MoM to CNY 629 million. - Shenzhen Airport: November passenger throughput up 8.77% YoY.
【Contracts & Bids】 - Chongqing Construction: Subsidiary wins CNY 1.71 billion construction project. - Jinggong Technology: Signs CNY 729 million sales contract with Hubei Yuchuang. - *ST Weihai (Rights Protection): Wins CNY 652 million Luoping smart agriculture project. - Jingce Electronics: Signs multiple contracts totaling CNY 433 million with same client over 12 months. - Heshun Electric: Pre-wins CNY 107 million State Grid tender. - Wanma Technology: Pre-wins CNY 59.94 million State Grid projects. - Zhongchao Holdings: Subsidiary secures CNY 51.56 million high-temperature alloy casting order. - Biointelli Technology: Pre-wins core mold tooling projects totaling CNY 27.5 million.
【Major Investments】 - Tiandi Technology: Plans R&D center for intelligent coal mining equipment. - Longjiang Transportation: Subsidiary to invest CNY 2.68 billion in 2M-ton graphite mining project. - Xingfu Electronics: Plans CNY 480 million electronic-grade phosphoric acid project. - Yongmaotai: Plans ~CNY 400 million Mg-Al alloy auto/robot parts project. - Tongyizhong: Plans ~CNY 198 million UHMWPE fiber project (2,400 tons/year).
【Others】 - Shuangta Food: Thai subsidiary production line operational. - Boyuan Chemical: Subsidiary’s Alashan Tamusu natural alkali project begins trial run. - Guangdong Electric Power: Unit 3 of Dapu Power Plant Phase II operational. - Hisoar Pharmaceutical: Partners with Hangzhou Advanced Research Institute for synthetic tech lab. - Huayi Group: Subsidiary Wanhao Co. halts production for environmental upgrades. - Zhangyue Technology: Receives CNY 4.99 million dividend from Dianzhong Technology. - LONGi Green Energy: Terminates overseas GDR issuance. - Tiandike: Chairman Chen You under investigation. - Yangfan New Materials: Controlling shareholder Fan Peiren released from investigation. - Nanhua Futures: Overseas subsidiary approved as Coinbase Derivatives member. - *ST Kaiwen: Other risk警示 lifted from Dec 11. - 3Peak: Terminates acquisition of Aura shares; trading resumes tomorrow. - Zhonghong Medical: Subsidiary product pre-selected for bulk procurement. - Fosun Pharma: Subsidiary signs licensing agreement with Pfizer. - Xingqi Eye Pharma: Completes first patient enrollment for SQ-22031 dry eye Phase II trial. - Dizal Pharma: Releases Gaoruizhe® and Birelentinib data at 67th ASH. - Dongcheng Pharmaceutical: Subsidiary’s dalteparin sodium injection approved for new specification. - *ST Nuotai (Rights Protection): Atosiban acetate injection approved. - Yuandong Bio: Brexpiprazole tablets approved. - New Industries: Medical device registration obtained. - Tiance Pharma: Subsidiary’s methimazole tablets approved. - Xianju Pharma: Nicardipine hydrochloride injection passes generic consistency evaluation. - Jiudian Pharmaceutical: JMHT06 clinical trial approved. - Xintiandi: Ferrous fumarate API approved. - Kehua Bio: Subsidiary’s medical device registration obtained. - David Medical: Subsidiary obtains 2 medical device registrations. - Fujilai: Lipoic acid tablets approved.
Comments